Ferritin as a potential biomarker of efficacy of treatment of atrial fibrillation - preliminary report

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2017, Vol 71, Issue

Abstract

<br/><b>Background</b>: Complex mechanisms of responsible for originating and maintaining of atrial fibrillation (AF) are involved in pathophysiology of this arrhythmia. Inflammation substantially contribute to arrhythmic remodelling of atrial tissue.The aim of the present study is to assess an applicability of ferritin and high sensitive C-reactive protein (hs-CRP) as biomarkers of atrial fibrillation and their usefulness in evaluation of efficacy of cryoablation. <br/><b>Materials and methods</b>: The study population consisted of 40 patients who underwent first AF cryoablation procedure. The whole follow-up time was for 6 months. The efficacy of cryoablation was defined as lack of episodes of AF longer than 30 s reported either in patient’s medical documentation or present in standard or Holter ECG records. Concentrations of hs-CRP (latex method ) and ferritin (immunochemical method) were determined in standard way in hospital laboratory. <br/><b>Results</b>: The recurrence of atrial fibrillation during follow-up was detected in 7 of 40 patients (efficacy 82.5%). Basal concentrations of hs-CRP and ferritin were significantly higher in patients who underwent ablation during AF. Ablation resulted in an increase of either hs-CRP or ferritin concentrations. After seven days, both hs-CRP and ferritin concentrations returned to basal level. The trend toward the higher concentration of hs-CRP was observed in AF recurrence subgroup in 30th and the 90th day after the procedure. Ferritin concentrations were significantly higher in recurrence subgroup after 30 and 90 days. <br/><b>Conclusion</b>: Our results suggest that the evaluation of ferritin serum level can be a potential tool for assessment of AF treatment efficacy.

Authors and Affiliations

Adam Sokal, Sylwia Wójcik, Patrycja Pruszkowska, Oskar Kowalski, Radoslaw Lenarczyk, Agnieszka Liberska, Michał Mazurek, Slawomir Pluta, Zbigniew Kalarus

Keywords

Related Articles

Szczepienia przeciwprątkowe – BCG i co dalej?

Gruźlica (TB) ciągle stanowi bardzo poważny światowy problem zdrowia publicznego. Występowanie TB jest zdecydowanie większe w regionach ubogich i o dużej gęstości zaludnienia (Afryka, Azja), niż w krajach postrzeganych...

Plants as an alternative source of therapeutic proteins

In recent years, there has been an increased interest of researchers in developing efficient plant heterologous expression systems of proteins for a wide range of applications. It represents an alternative to the traditi...

Role of oncogene 24p3 neutrophil gelatinase-associated lipocalin (NGAL) in digestive system cancers

Neutrophil gelatinase-associated lipocalin, known also as 24p3 lipocalin, lipocalin-2 or uterocalin (in mouse), is a small secretory protein binding small molecular weight ligands which takes part in numerous processes i...

Stres i jego molekularne konsekwencje w rozwoju choroby nowotworowej

Stres jako niekorzystna dla organizmu sytuacja wywołana czynnikami psychologicznymi, fizjologicznymi czy fizycznymi zaburza jego homeostazę. Rozróżnia się dwa rodzaje stresu: krótkotrwały oraz chroniczny. Chorobie nowotw...

Download PDF file
  • EP ID EP227450
  • DOI 10.5604/01.3001.0010.5267
  • Views 200
  • Downloads 0

How To Cite

Adam Sokal, Sylwia Wójcik, Patrycja Pruszkowska, Oskar Kowalski, Radoslaw Lenarczyk, Agnieszka Liberska, Michał Mazurek, Slawomir Pluta, Zbigniew Kalarus (2017). Ferritin as a potential biomarker of efficacy of treatment of atrial fibrillation - preliminary report. Advances in Hygiene and Experimental Medicine, 71(), 876-880. https://europub.co.uk/articles/-A-227450